ACM Research (Shanghai) Bilan de santé

Santé financière contrôle des critères 5/6

ACM Research (Shanghai) has a total shareholder equity of CN¥7.2B and total debt of CN¥1.1B, which brings its debt-to-equity ratio to 15.5%. Its total assets and total liabilities are CN¥11.4B and CN¥4.2B respectively. ACM Research (Shanghai)'s EBIT is CN¥956.3M making its interest coverage ratio -17.1. It has cash and short-term investments of CN¥2.1B.

Informations clés

15.5%

Ratio d'endettement

CN¥1.11b

Dette

Ratio de couverture des intérêts	-17.1x
Argent liquide	CN¥2.15b
Fonds propres	CN¥7.18b
Total du passif	CN¥4.18b
Total des actifs	CN¥11.37b

Mises à jour récentes de la santé financière

Does ACM Research (Shanghai) (SHSE:688082) Have A Healthy Balance Sheet?

Sep 13

These 4 Measures Indicate That ACM Research (Shanghai) (SHSE:688082) Is Using Debt Reasonably Well

Jun 08

Recent updates

Does ACM Research (Shanghai) (SHSE:688082) Have A Healthy Balance Sheet?

Sep 13

There Are Reasons To Feel Uneasy About ACM Research (Shanghai)'s (SHSE:688082) Returns On Capital

Jul 13

These 4 Measures Indicate That ACM Research (Shanghai) (SHSE:688082) Is Using Debt Reasonably Well

Jun 08

We Think That There Are Some Issues For ACM Research (Shanghai) (SHSE:688082) Beyond Its Promising Earnings

May 03

Investors Still Waiting For A Pull Back In ACM Research (Shanghai), Inc. (SHSE:688082)

Apr 21

Analyse de la situation financière

Passif à court terme: 688082's short term assets (CN¥8.9B) exceed its short term liabilities (CN¥3.4B).

Passif à long terme: 688082's short term assets (CN¥8.9B) exceed its long term liabilities (CN¥779.4M).

Historique et analyse du ratio d'endettement

Niveau d'endettement: 688082 has more cash than its total debt.

Réduire la dette: 688082's debt to equity ratio has increased from 13.5% to 15.5% over the past 5 years.

Couverture de la dette: 688082's debt is well covered by operating cash flow (35.8%).

Couverture des intérêts: 688082 earns more interest than it pays, so coverage of interest payments is not a concern.

ACM Research (Shanghai) Bilan de santé

Santé financière contrôle des critères 5/6

Informations clés

Mises à jour récentes de la santé financière

Does ACM Research (Shanghai) (SHSE:688082) Have A Healthy Balance Sheet?

These 4 Measures Indicate That ACM Research (Shanghai) (SHSE:688082) Is Using Debt Reasonably Well

Recent updates

Third quarter 2024 earnings: EPS and revenues miss analyst expectations

Investor sentiment deteriorates as stock falls 15%

Price target decreased by 10.0% to CN¥110

New minor risk - Share price stability

ACM Research (Shanghai), Inc. to Report Q3, 2024 Results on Oct 31, 2024

Investor sentiment improves as stock rises 16%

Price target decreased by 10% to CN¥114

Does ACM Research (Shanghai) (SHSE:688082) Have A Healthy Balance Sheet?

ACM Research (Shanghai), Inc. (SHSE:688082) announces an Equity Buyback for CNY 100 million worth of its shares.

Dividend of CN¥0.63 announced

There Are Reasons To Feel Uneasy About ACM Research (Shanghai)'s (SHSE:688082) Returns On Capital

Price target increased by 7.1% to CN¥136

ACM Research (Shanghai), Inc. to Report First Half, 2024 Results on Aug 08, 2024

These 4 Measures Indicate That ACM Research (Shanghai) (SHSE:688082) Is Using Debt Reasonably Well

ACM Research (Shanghai), Inc., Annual General Meeting, Jun 18, 2024

We Think That There Are Some Issues For ACM Research (Shanghai) (SHSE:688082) Beyond Its Promising Earnings

First quarter 2024 earnings: EPS and revenues miss analyst expectations

Investors Still Waiting For A Pull Back In ACM Research (Shanghai), Inc. (SHSE:688082)

ACM Research (Shanghai), Inc. to Report Q1, 2024 Results on Apr 27, 2024

New minor risk - Dividend sustainability

Investor sentiment deteriorates as stock falls 17%

ACM Research (Shanghai), Inc. announced that it expects to receive CNY 4.500000013 billion in funding

ACM Research (Shanghai), Inc. announced that it expects to receive CNY 4.499999992 billion in funding

ACM Research (Shanghai), Inc. to Report Fiscal Year 2023 Results on Feb 29, 2024

Consensus EPS estimates increase by 14%

ACM Research (Shanghai), Inc. to Report Nine Months, 2023 Results on Oct 27, 2023

Price target increased by 8.0% to CN¥124

ACM Research (Shanghai), Inc. Introduces Vacuum Cleaning Platform Targeting the Rapidly Growing Chiplets Industry

Second quarter 2023 earnings: EPS and revenues exceed analyst expectations

Consensus EPS estimates increase by 10%

ACM Research (Shanghai), Inc. Approves Cash Dividend

ACM Research (Shanghai), Inc. to Report First Half, 2023 Results on Aug 05, 2023

Price target increased by 9.3% to CN¥115

Investor sentiment deteriorates as stock falls 16%

Investor sentiment improves as stock rises 16%

Consensus EPS estimates increase by 15%

ACM Research (Shanghai), Inc. (SHSE:688082) agreed to acquire 20% stake in Ninebell Co., Ltd. for $16.7 million.

ACM Research (Shanghai), Inc. to Report Q4, 2022 Results on Feb 24, 2023

ACM Research (Shanghai), Inc. Introduces Ultra Track Tool, Marking Its Entry into the Track Market

Less than half of directors are independent

Investor sentiment deteriorated over the past week

Consensus EPS estimates increase by 34%

Less than half of directors are independent

Less than half of directors are independent

Analyse de la situation financière

Historique et analyse du ratio d'endettement

Bilan

Découvrir des entreprises saines